Insights On Outsourced Drug Development

1. Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions 6/16/2025

   Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.

2. Tackling The Drug Development Crisis Using Improved Preclinical Models 2/13/2024

   The productivity of drug development has sharply declined over the past seven decades. Discover how improving preclinical models holds the key to solving the challenge at the heart of drug development.

3. API In Capsule Vs. The Lost Art Of Formulation Development 11/5/2025

   API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.

4. Proximal Tubule Kidney-Chip For Modeling Human Physiology 3/14/2024

   Discover how an Organ-Chip can be used to create a comprehensive recapitulation of the proximal tubule, addressing the need for more human-relevant preclinical models in the pharmaceutical industry.

5. The Complete Guide To Immunohistochemistry 9/24/2024

   Immunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.

6. Enable Low Volume Delivery Of Proteins In Aqueous Solutions 11/7/2025

   Achieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.

7. A New Framework For Identifying Nitrosamine Risks And Derisking Products 6/18/2024

   Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

8. What Are Organ-Chips? 2/13/2024

   Learn in detail about Organ-on-a-Chip technology and how it is paving the way for the next generation of drug development and research.

9. Quicker Development Using Cell Line Integration, End-To-End Support 6/19/2025

   Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.

10. Advancement Of Upstream Bioprocess Intensification 7/1/2025

    Explore how two companies unite to streamline upstream process intensification with integrative technology to boost efficiency, scalability, and innovation in biopharmaceutical manufacturing.